Concepedia

Publication | Open Access

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

25

Citations

29

References

2017

Year

Abstract

EPCR represents a clinically relevant factor associated with poor outcome and a novel vulnerability to develop combination therapies for breast cancer patients.

References

YearCitations

2012

67.6K

2005

2.7K

2003

2.6K

2005

1.2K

2011

846

2013

568

1996

526

2009

378

2014

341

2012

294

Page 1